A new method to analyze gene interactions in cancer using single-cell data
scDECO: A novel statistical framework to identify differential co-expression gene combinations systematically using single-cell RNA sequencing data
This study is looking at how genes work together in cancer by using advanced technology to analyze tiny samples of cancer cells, which could help doctors find better treatments for patients with melanoma and prostate cancer.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Carolina at Columbia NIH-funded |
| Lab location | 1 site (Columbia, United States) |
| Project ID | NIH-10474599 on NIH RePORTER |
What this research studies
This research focuses on developing a novel statistical framework called scDECO to analyze gene interactions in cancer by utilizing single-cell RNA sequencing data. The approach aims to improve the identification of differential co-expression gene combinations, which can reveal how different genes interact under various conditions. By applying this method to datasets from melanoma and prostate cancer, the research seeks to enhance our understanding of tumor biology and the complexity of cancer ecosystems. Patients may benefit from insights gained through this analysis, which could lead to more targeted and effective treatments.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with melanoma or prostate cancer who have circulating tumor cells.
Not a fit: Patients with non-malignant conditions or those without circulating tumor cells may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding of cancer biology and more personalized treatment strategies for patients.
How similar studies have performed: Other research has shown success in using advanced statistical methods for gene analysis, indicating that this approach has the potential to yield valuable insights.
Where this research is happening
Columbia, United States
- University of South Carolina at Columbia — Columbia, United States (Active)
Researchers
- Principal investigator: Ho, Yen-Yi — University of South Carolina at Columbia
- Study coordinator: Ho, Yen-Yi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.